Home>>Signaling Pathways>> Microbiology & Virology>> HCV>>Tris(4-aminophenyl)methane (Leucopararosaniline)

Tris(4-aminophenyl)methane (Leucopararosaniline)

Catalog No.GC32392

Tris(4-aminophenyl)methane (Leucopararosaniline) is a triphenylmethane dye.

Products are for research use only. Not for human use. We do not sell to patients.

Tris(4-aminophenyl)methane (Leucopararosaniline) Chemical Structure

Cas No.: 548-61-8

Size Price Stock Qty
100mg
$41.00
In stock
250mg
$81.00
In stock
500mg
$110.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tris(4-aminophenyl)methane is a triphenylmethane dye. Tris(4-aminophenyl)methane is a weak HCV helicase inhibitor.

Tris(4-aminophenyl)methane (Compound 8) shows weak HCV helicase inhibition (30% inhibition at 100 μM)[1]. To preserve RNA in a biological sample for analysis, the sample is incubated with an RNA preservative capable of precipitating RNA in an aqueous solution, such as a triphenylmethane dye (e.g., methyl green, crystal violet, pararosaniline, or Tris(4-aminophenyl)methane), cresyl violet, or cobalt ions. RNA preservation may be used in an immunostaining assay and other histochemical methods[2].

[1]. Chen CS, et al. Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virushelicase. J Med Chem. 2009 May 14;52(9):2716-23.

Reviews

Review for Tris(4-aminophenyl)methane (Leucopararosaniline)

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tris(4-aminophenyl)methane (Leucopararosaniline)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.